Virus-Specific T Cells for the Immunocompromised Patient

por Houghtelin, Amy, Bollard, Catherine M.
Publicado 2017

Celebrating a year of clinical and translational research in Blood Advances

por Bollard, Catherine M., Weyrich, Andrew
Publicado 2022

Controlling Cytomegalovirus: Helping the Immune System Take the Lead

por Hanley, Patrick J., Bollard, Catherine M.
Publicado 2014

Immunologic special forces: anti-pathogen cytotoxic T-lymphocyte immunotherapy following hematopoietic stem cell transplantation

por Keller, Michael D, Bollard, Catherine M
Publicado 2014

Specific Adoptive T-Cell Therapy for Viral and Fungal Infections

por Lum, Lawrence G., Bollard, Catherine M.
Publicado 2018

Gene Therapy for Pediatric Cancer: State of the Art and Future Perspectives

por Biagi, Ettore, Bollard, Catherine, Rousseau, Raphael, Brenner, Malcolm
Publicado 2003

The time is now: moving toward virus-specific T cells after allogeneic hematopoietic stem cell transplantation as the standard of care

por Saglio, Francesco, Hanley, Patrick J., Bollard, Catherine M.
Publicado 2014

Cellular therapies for the treatment and prevention of SARS-CoV-2 infection

por Conway, Susan R., Keller, Michael D., Bollard, Catherine M.
Publicado 2022

Immunotherapy for Epstein-Barr Virus-Related Lymphomas

por Kennedy-Nasser, Alana A., Bollard, Catherine M., Heslop, Helen E.
Publicado 2009

Adoptive T Cell Therapy for Epstein–Barr Virus Complications in Patients With Primary Immunodeficiency Disorders

por McLaughlin, Lauren P., Bollard, Catherine M., Keller, Michael D.
Publicado 2018

Virus-Specific T Cell Therapies for HIV: Lessons Learned From Hematopoietic Stem Cell Transplantation

por Lee, Ping-Hsien, Keller, Michael D., Hanley, Patrick J., Bollard, Catherine M.
Publicado 2020

A single exercise bout enhances the manufacture of viral-specific T-cells from healthy donors: implications for allogeneic adoptive transfer immunotherapy

por Spielmann, Guillaume, Bollard, Catherine M., Kunz, Hawley, Hanley, Patrick J., Simpson, Richard J.
Publicado 2016

IMMU-22. ALLOGENEIC NK CELLS SECRETING IL15 AND RESISTANT TO TGF-β Show Antitumor Activity Against Gliobastoma

por Muniraj, Nethaji, Chaudhry, Kajal, Terao, Joshua, Barron, Luke, Suri, Vipin, Bollard, Catherine, Cruz, Conrad Russell
Publicado 2023

IMMU-15. PROTEOGENOMIC DISCOVERY OF NOVEL TUMOR PEPTIDES AS NEOANTIGENS FOR PERSONALIZED T CELL IMMUNOTHERAPY IN MEDULLOBLASTOMA

por Rivero-Hinojosa, Samuel, Grant, Melanie, Panigrahi, Aswini, Zhang, Huizhen, Caisova, Veronika, Bollard, Catherine, Rood, Brian
Publicado 2020

Novel TCR-like CAR-T cells targeting an HLA∗0201-restricted SSX2 epitope display strong activity against acute myeloid leukemia

por Raskin, Scott, Van Pelt, Stacey, Toner, Keri, Balakrishnan, Preethi Bala, Dave, Hema, Bollard, Catherine M., Yvon, Eric
Publicado 2021

Proteogenomic discovery of neoantigens facilitates personalized multi-antigen targeted T cell immunotherapy for brain tumors

por Rivero-Hinojosa, Samuel, Grant, Melanie, Panigrahi, Aswini, Zhang, Huizhen, Caisova, Veronika, Bollard, Catherine M., Rood, Brian R.
Publicado 2021

Indocyanine Green-Nexturastat A-PLGA Nanoparticles Combine Photothermal and Epigenetic Therapy for Melanoma

por Ledezma, Debbie K., Balakrishnan, Preethi B., Cano-Mejia, Juliana, Sweeney, Elizabeth E., Hadley, Melissa, Bollard, Catherine M., Villagra, Alejandro, Fernandes, Rohan
Publicado 2020

Toward a Rapid Production of Multivirus-Specific T Cells Targeting BKV, Adenovirus, CMV, and EBV from Umbilical Cord Blood

por Dave, Hema, Luo, Min, Blaney, J.W., Patel, Shabnum, Barese, Cecilia, Cruz, Conrad Russell, Shpall, Elizabeth J., Bollard, Catherine M., Hanley, Patrick J.
Publicado 2017

Brentuximab vedotin in combination with chemotherapy for pediatric patients with ALK(+) ALCL: results of COG trial ANHL12P1

por Lowe, Eric J., Reilly, Anne F., Lim, Megan S., Gross, Thomas G., Saguilig, Lauren, Barkauskas, Donald A., Wu, Rui, Alexander, Sarah, Bollard, Catherine M.
Publicado 2021

Emerging trends in COVID-19 treatment: learning from inflammatory conditions associated with cellular therapies

por Cancio, Maria, Ciccocioppo, Rachele, Rocco, Patricia R.M., Levine, Bruce L., Bronte, Vincenzo, Bollard, Catherine M., Weiss, Daniel, Boelens, Jaap Jan, Hanley, Patrick J.
Publicado 2020